1. Home
  2. VCEL vs ENOV Comparison

VCEL vs ENOV Comparison

Compare VCEL & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$32.94

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Enovis Corporation

ENOV

Enovis Corporation

HOLD

Current Price

$24.34

Market Cap

1.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
VCEL
ENOV
Founded
1989
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Fluid Controls
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
1996
2008

Fundamental Metrics

Financial Performance
Metric
VCEL
ENOV
Price
$32.94
$24.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
9
Target Price
$57.75
$47.38
AVG Volume (30 Days)
577.3K
1.0M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
60.00
N/A
EPS
N/A
N/A
Revenue
$276,259,000.00
N/A
Revenue This Year
$19.40
$6.36
Revenue Next Year
$18.24
$5.31
P/E Ratio
N/A
N/A
Revenue Growth
16.45
N/A
52 Week Low
$28.95
$21.00
52 Week High
$45.97
$36.82

Technical Indicators

Market Signals
Indicator
VCEL
ENOV
Relative Strength Index (RSI) 43.49 49.23
Support Level $30.41 $21.52
Resistance Level $34.77 $27.11
Average True Range (ATR) 2.05 1.46
MACD -0.35 0.06
Stochastic Oscillator 12.24 39.49

Price Performance

Historical Comparison
VCEL
ENOV

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About ENOV Enovis Corporation

Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.

Share on Social Networks: